Why Does Plasma Form Such Robust Fibrin Clots – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by François Caton et al, adding:
“Why does plasma form such robust fibrin clots?
Fibrin clot architecture is a recognised signature of cardiovascular disease, but the fundamental mechanisms linking clot-forming chemistry to clot structure in plasma remain poorly understood. A new study in RPTH Journal takes a rigorous quantitative approach to answer this question.
Key findings comparing plasma clots with purified fibrinogen/thrombin systems:
In purified systems, a 100-fold increase in thrombin concentration caused a 30-fold decrease in protofibril number and a 5-fold change in pore size, highly sensitive to trigger concentration
In contrast, plasma clots showed remarkable robustness: a 40-fold increase in tissue factor concentration resulted in only a 2-fold change in protofibril number, with minimal pore size evolution
Purified and plasma clots appeared morphologically identical, their ultrastructural parameters behaved fundamentally differently
Key driver: it is the characteristic shape of the thrombin burst over time, not the total amount of thrombin produced, that governs plasma fibrin architecture
This inherent robustness of plasma clot formation may explain the existence of a ‘normal’ clot structure, and positions fibrinography as a promising structural biomarker for detecting deviations from this norm in cardiovascular disease.”
Title: Thrombin kinetics determines robust plasma clot architecture
Authors: François Caton, Landry Seyve, Carhel Dassi, Denis Roux, Benoît Polack
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 27, 2026, 14:11Sontyana Jyothi Swarupa: Dr Wolfgang Willenbacher Joins ISHBD 2027 Organising Committee
-
Sep 27, 2026, 13:58Thrombin-Trained Immunity and the Biology of Recurrent VTE
-
Sep 27, 2026, 13:31Mohamud Abdullahi Mohamed: Essential Resource for Clinical Hematology Diagnostics
-
Sep 27, 2026, 13:19Julie Makani: Advances and Challenges in Sickle Cell and Beta Thalassemia Treatment
-
Sep 27, 2026, 12:56Ana Lidia Flores-Mireles: Fibrin Suppresses Macrophage Defenses in Catheter-Associated UTIs
-
Sep 27, 2026, 12:30Francesco Onida: Maria Domenica Cappellini Receives 2026 Lettura Ferrata Award
-
Sep 27, 2026, 11:51Ashraf Dada: Smart Algorithm Enables Successful Single-Session Stem Cell Collection
-
Sep 27, 2026, 09:03Tareq Abadl: Hemoglobin Electrophoresis Patterns Across Thalassemia Syndromes
-
Sep 27, 2026, 08:33Vincent Serra: Beyond Oncology The Expanding Landscape of Immunotherapy